BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 25126561)

  • 1. The roles of CD73 in cancer.
    Gao ZW; Dong K; Zhang HZ
    Biomed Res Int; 2014; 2014():460654. PubMed ID: 25126561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.
    Gao ZW; Wang HP; Lin F; Wang X; Long M; Zhang HZ; Dong K
    BMC Cancer; 2017 Feb; 17(1):135. PubMed ID: 28202050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody-Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function.
    Jin R; Liu L; Xing Y; Meng T; Ma L; Pei J; Cong Y; Zhang X; Ren Z; Wang X; Shen J; Yu K
    Mol Cancer Ther; 2020 Nov; 19(11):2340-2352. PubMed ID: 32943546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model.
    Tsukui H; Horie H; Koinuma K; Ohzawa H; Sakuma Y; Hosoya Y; Yamaguchi H; Yoshimura K; Lefor AK; Sata N; Kitayama J
    BMC Cancer; 2020 May; 20(1):411. PubMed ID: 32397971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD73 is associated with poor prognosis in high-grade serous ovarian cancer.
    Turcotte M; Spring K; Pommey S; Chouinard G; Cousineau I; George J; Chen GM; Gendoo DM; Haibe-Kains B; Karn T; Rahimi K; Le Page C; Provencher D; Mes-Masson AM; Stagg J
    Cancer Res; 2015 Nov; 75(21):4494-503. PubMed ID: 26363007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo.
    Salehi Khesht AM; Karpisheh V; Sahami Gilan P; Melnikova LA; Olegovna Zekiy A; Mohammadi M; Hojjat-Farsangi M; Majidi Zolbanin N; Mahmoodpoor A; Hassannia H; Aghebati-Maleki L; Jafari R; Jadidi-Niaragh F
    Int J Biol Macromol; 2021 Sep; 186():849-863. PubMed ID: 34245737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells.
    Romio M; Reinbeck B; Bongardt S; Hüls S; Burghoff S; Schrader J
    Am J Physiol Cell Physiol; 2011 Aug; 301(2):C530-9. PubMed ID: 21593451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of CD73 on human colorectal cancer cell growth in vivo and in vitro.
    Wu R; Chen Y; Li F; Li W; Zhou H; Yang Y; Pei Z
    Oncol Rep; 2016 Mar; 35(3):1750-6. PubMed ID: 26708311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration.
    Koszałka P; Gołuńska M; Urban A; Stasiłojć G; Stanisławowski M; Majewski M; Składanowski AC; Bigda J
    PLoS One; 2016; 11(3):e0151420. PubMed ID: 26964090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular 5'-nucleotidase (CD73) promotes human breast cancer cells growth through AKT/GSK-3β/β-catenin/cyclinD1 signaling pathway.
    Yu J; Wang X; Lu Q; Wang J; Li L; Liao X; Zhu W; Lv L; Zhi X; Yu J; Jin Y; Zou Q; Ou Z; Liu X; Zhou P
    Int J Cancer; 2018 Mar; 142(5):959-967. PubMed ID: 29047106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The volatile anesthetic isoflurane induces ecto-5'-nucleotidase (CD73) to protect against renal ischemia and reperfusion injury.
    Kim M; Ham A; Kim JY; Brown KM; D'Agati VD; Lee HT
    Kidney Int; 2013 Jul; 84(1):90-103. PubMed ID: 23423261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first CD73-instructed supramolecular hydrogel.
    Wu D; Du X; Shi J; Zhou J; Zhou N; Xu B
    J Colloid Interface Sci; 2015 Jun; 447():269-72. PubMed ID: 25524006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of ecto-5'-nucleotidase/CD73 in glioma cell line proliferation.
    Bavaresco L; Bernardi A; Braganhol E; Cappellari AR; Rockenbach L; Farias PF; Wink MR; Delgado-Cañedo A; Battastini AM
    Mol Cell Biochem; 2008 Dec; 319(1-2):61-8. PubMed ID: 18636315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis.
    Koszałka P; Gołuńska M; Stanisławowski M; Urban A; Stasiłojć G; Majewski M; Wierzbicki P; Składanowski AC; Bigda J
    Int J Biochem Cell Biol; 2015 Dec; 69():1-10. PubMed ID: 26545615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and Function of Non-cell-bound CD73 in Inflammation.
    Schneider E; Rissiek A; Winzer R; Puig B; Rissiek B; Haag F; Mittrücker HW; Magnus T; Tolosa E
    Front Immunol; 2019; 10():1729. PubMed ID: 31404305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression and clinical significance of CD73 molecule in human rectal adenocarcinoma.
    Zhang B; Song B; Wang X; Chang XS; Pang T; Zhang X; Yin K; Fang GE
    Tumour Biol; 2015 Jul; 36(7):5459-66. PubMed ID: 25677906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer.
    Chen Q; Pu N; Yin H; Zhang J; Zhao G; Lou W; Wu W
    J Cell Mol Med; 2020 Aug; 24(15):8674-8686. PubMed ID: 32643277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line.
    Dietrich F; Figueiró F; Filippi-Chiela EC; Cappellari AR; Rockenbach L; Tremblay A; de Paula PB; Roesler R; Filho AB; Sévigny J; Morrone FB; Battastini AMO
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):469-482. PubMed ID: 29305710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distinct role of CD73 in the progression of pancreatic cancer.
    Zhou L; Jia S; Chen Y; Wang W; Wu Z; Yu W; Zhang M; Ding G; Cao L
    J Mol Med (Berl); 2019 Jun; 97(6):803-815. PubMed ID: 30927045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.
    Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.